EUVIMEDEUVIMED entdecken
Open Access

Survival Outcomes of Adjuvant Nivolumab after Neoadjuvant Chemotherapy in Esophageal Squamous Cell Carcinoma

Ruihan Zeng, Shinji Mine, Motomi Nasu, Takashi Hashimoto, Rie Makuuchi, Asako Ozaki, Yutaro Yoshimoto, Takehiro Watanabe, Shotaro Takai, Tetsu Fukunaga

Annals of Thoracic and Cardiovascular Surgery · 2026 · 32 (1) · n/a

DOI: 10.5761/atcs.oa.26-00107 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Thoracic and Cardiovascular Surgery, 2026. Verfasst von Ruihan Zeng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Esophageal and Gastroenterological Surgery, Juntendo University, Tokyo, Japan. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Nivolumab, Neoadjuvant Therapy, Esophagectomy. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Esophageal NeoplasmsNivolumabNeoadjuvant TherapyEsophagectomyEsophageal Squamous Cell CarcinomaImmune Checkpoint InhibitorsAntineoplastic Agents, ImmunologicalHumansChemotherapy, AdjuvantFemaleRetrospective StudiesMaleTime FactorsAgedMiddle AgedRisk FactorsDisease-Free SurvivalTreatment OutcomeRisk AssessmentNeoplasm Recurrence, Local

Stichwörter der Autor:innen

disease-free survivalesophageal squamous cell carcinomaimmune-related adverse eventnivolumaboverall survival

Substanzen

NivolumabImmune Checkpoint InhibitorsAntineoplastic Agents, Immunological

Autor:innen und Institutionen

  • Department of Esophageal and Gastroenterological Surgery, Juntendo University, Tokyo, Japan.

Zitieren

APA

Zeng, R., Mine, S., Nasu, M., Hashimoto, T., Makuuchi, R., Ozaki, A., Yoshimoto, Y., Watanabe, T., Takai, S., & Fukunaga, T. (2026). Survival Outcomes of Adjuvant Nivolumab after Neoadjuvant Chemotherapy in Esophageal Squamous Cell Carcinoma. Annals of Thoracic and Cardiovascular Surgery, 32(1), n/a. https://doi.org/10.5761/atcs.oa.26-00107

Vancouver

Zeng R, Mine S, Nasu M, Hashimoto T, Makuuchi R, Ozaki A, et al. Survival Outcomes of Adjuvant Nivolumab after Neoadjuvant Chemotherapy in Esophageal Squamous Cell Carcinoma. Annals of Thoracic and Cardiovascular Surgery. 2026;32(1):n/a. doi:10.5761/atcs.oa.26-00107

BibTeX
@article{Zeng2026,
  author = {Zeng, Ruihan and Mine, Shinji and Nasu, Motomi and Hashimoto, Takashi and Makuuchi, Rie and Ozaki, Asako and Yoshimoto, Yutaro and Watanabe, Takehiro and Takai, Shotaro and Fukunaga, Tetsu},
  title = {Survival Outcomes of Adjuvant Nivolumab after Neoadjuvant Chemotherapy in Esophageal Squamous Cell Carcinoma},
  journal = {Annals of Thoracic and Cardiovascular Surgery},
  year = {2026},
  volume = {32},
  number = {1},
  pages = {n/a},
  doi = {10.5761/atcs.oa.26-00107}
}
Kostenlos starten →